These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23237839)

  • 1. Isatin replacements applied to the highly selective, muscarinic M1 PAM ML137: continued optimization of an MLPCN probe molecule.
    Melancon BJ; Poslusney MS; Gentry PR; Tarr JC; Sheffler DJ; Mattmann ME; Bridges TM; Utley TJ; Daniels JS; Niswender CM; Conn PJ; Lindsley CW; Wood MR
    Bioorg Med Chem Lett; 2013 Jan; 23(2):412-6. PubMed ID: 23237839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spirocyclic replacements for the isatin in the highly selective, muscarinic M1 PAM ML137: the continued optimization of an MLPCN probe molecule.
    Poslusney MS; Melancon BJ; Gentry PR; Sheffler DJ; Bridges TM; Utley TJ; Daniels JS; Niswender CM; Conn PJ; Lindsley CW; Wood MR
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1860-4. PubMed ID: 23416001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a more highly selective M(1) antagonist from the continued optimization of the MLPCN Probe ML012.
    Melancon BJ; Lamers AP; Bridges TM; Sulikowski GA; Utley TJ; Sheffler DJ; Noetzel MJ; Morrison RD; Daniels JS; Niswender CM; Jones CK; Conn PJ; Lindsley CW; Wood MR
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1044-8. PubMed ID: 22197142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and optimization of a novel, selective and brain penetrant M1 positive allosteric modulator (PAM): the development of ML169, an MLPCN probe.
    Reid PR; Bridges TM; Sheffler DJ; Cho HP; Lewis LM; Days E; Daniels JS; Jones CK; Niswender CM; Weaver CD; Conn PJ; Lindsley CW; Wood MR
    Bioorg Med Chem Lett; 2011 May; 21(9):2697-701. PubMed ID: 21194936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory potency of some isatin analogues on human monoamine oxidase A and B.
    Medvedev AE; Goodwin B; Clow A; Halket J; Glover V; Sandler M
    Biochem Pharmacol; 1992 Aug; 44(3):590-2. PubMed ID: 1510706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 3-Hydroxy-3-phenacyloxindole Analogues of Isatin as Potential Monoamine Oxidase Inhibitors.
    Tripathi RK; Krishnamurthy S; Ayyannan SR
    ChemMedChem; 2016 Jan; 11(1):119-32. PubMed ID: 26592797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of monoamine oxidase by (E)-styrylisatin analogues.
    Van der Walt EM; Milczek EM; Malan SF; Edmondson DE; Castagnoli N; Bergh JJ; Petzer JP
    Bioorg Med Chem Lett; 2009 May; 19(9):2509-13. PubMed ID: 19342233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins.
    Bridges TM; Marlo JE; Niswender CM; Jones CK; Jadhav SB; Gentry PR; Plumley HC; Weaver CD; Conn PJ; Lindsley CW
    J Med Chem; 2009 Jun; 52(11):3445-8. PubMed ID: 19438238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel M1 antagonist scaffolds through the continued optimization of the MLPCN probe ML012.
    Melancon BJ; Utley TJ; Sevel C; Mattmann ME; Cheung YY; Bridges TM; Morrison RD; Sheffler DJ; Niswender CM; Daniels JS; Conn PJ; Lindsley CW; Wood MR
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5035-40. PubMed ID: 22749871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of monoamine oxidase by C5-substituted phthalimide analogues.
    Manley-King CI; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2011 Aug; 19(16):4829-40. PubMed ID: 21778064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of indole derivatives with monoamine oxidase A and B. Studies on the structure-inhibitory activity relationship.
    Medvedev AE; Ivanov AS; Kamyshanskaya NS; Kirkel AZ; Moskvitina TA; Gorkin VZ; Li NY; Marshakov VYu
    Biochem Mol Biol Int; 1995 May; 36(1):113-22. PubMed ID: 7663405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of brain mitochondrial monoamine oxidases by the endogenous compound 5-hydroxyoxindole.
    Crumeyrolle-Arias M; Tournaire MC; Cane A; Launay JM; Barritault D; Medvedev A
    Biochem Pharmacol; 2004 Mar; 67(5):977-9. PubMed ID: 15104251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of monoamine oxidase by selected C5- and C6-substituted isatin analogues.
    Manley-King CI; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2011 Jan; 19(1):261-74. PubMed ID: 21134756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the mechanism of inhibition of tryptophan 2,3-dioxygenase by isatin derivatives.
    Pantouris G; Loudon-Griffiths J; Mowat CG
    J Enzyme Inhib Med Chem; 2016; 31(sup1):70-78. PubMed ID: 27096472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isatin analogs as novel inhibitors of Candida spp. β-carbonic anhydrase enzymes.
    Akdemir A; Güzel-Akdemir Ö; Karalı N; Supuran CT
    Bioorg Med Chem; 2016 Apr; 24(8):1648-52. PubMed ID: 26951893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.
    Melancon BJ; Gogliotti RD; Tarr JC; Saleh SA; Chauder BA; Lebois EP; Cho HP; Utley TJ; Sheffler DJ; Bridges TM; Morrison RD; Daniels JS; Niswender CM; Conn PJ; Lindsley CW; Wood MR
    Bioorg Med Chem Lett; 2012 May; 22(10):3467-72. PubMed ID: 22507963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental and Computational Evaluation of Piperonylic Acid Derived Hydrazones Bearing Isatin Moieties as Dual Inhibitors of Cholinesterases and Monoamine Oxidases.
    Vishnu MS; Pavankumar V; Kumar S; Raja AS
    ChemMedChem; 2019 Jul; 14(14):1359-1376. PubMed ID: 31177620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells.
    Hall MD; Salam NK; Hellawell JL; Fales HM; Kensler CB; Ludwig JA; Szakács G; Hibbs DE; Gottesman MM
    J Med Chem; 2009 May; 52(10):3191-204. PubMed ID: 19397322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of ML326: The first sub-micromolar, selective M5 PAM.
    Gentry PR; Bridges TM; Lamsal A; Vinson PN; Smith E; Chase P; Hodder PS; Engers JL; Niswender CM; Daniels JS; Conn PJ; Wood MR; Lindsley CW
    Bioorg Med Chem Lett; 2013 May; 23(10):2996-3000. PubMed ID: 23562060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro evaluation of sulfonamide isatin Michael acceptors as small molecule inhibitors of caspase-6.
    Chu W; Rothfuss J; Chu Y; Zhou D; Mach RH
    J Med Chem; 2009 Apr; 52(8):2188-91. PubMed ID: 19326941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.